The key performance indicators for monitoring and reporting our performance, and our plans for 2020, are summarised below.
Food quality and security
Advancing genetic improvement in food-producing animals, through technology and innovation
Highlights in the year
- Drove further genetic improvement in both porcine and bovine species
- Continued our work to combat PRRSv in pigs and signed a major collaboration agreement in China
- Increased the availability of Sexcel in target markets around the world
What we plan to do next
- Continue driving porcine and bovine genetic improvement and rapidly disseminate the genetics to customers globally
- Continue responsible development of gene editing technology, to aid disease eradication and animal wellbeing
Animal well-being
Continuously improve animal welfare practices across our business worldwide
HIGHLIGHTS IN THE YEAR
- Continued to invest in PIC and ABS animal housing facilities
- Continued aligning standard operating procedures across the PIC supply chain
- Maintained our focus on reducing bovine stress, to improve maternal health
WHAT WE PLAN TO DO NEXT
- Ensure employees with animal care responsibilities are routinely trained on current animal care standards
- Continue investment in animal housing facilities
- Keep reviewing and updating animal care standards and operating procedures, to maintain alignment with best practice
- Educate the industry on how Sexcel can significantly increase unassisted birthing of calves
Environment
Ensuring Genus is a proper steward of all environmental resources
Highlights in the year
- Audited 80.3% of PIC-owned production sites
- Improved feed efficiency by 0.02 kg of feed per kg of pork
- Completed roll-out of eco-friendly porcine semen packaging solution in Mexico
What we plan to do next
- Maintain scope and measures of PIC audits on owned production, including 80% of owned sites
- Improve feed efficiency by 0.02 kg of feed per kg of pork per annum
- Continue to evolve beef genetics that improve feed efficiency and reduce greenhouse gas emissions
- Explore opportunities for wider deployment of renewable energy solutions across ABS and PIC sites
- Work to address nutrient management challenges by exploring technological innovations
- Work to minimize packaging waste across genetic dissemination devices in global distribution channels
Health and Safety
Ensure a safe working environment for our colleagues
Highlights in the year
- Vehicle incidents rose slightly by 2%
- Recordable incidents dropped by 7%, although the proportion of animal-related injuries rose by 4%
What we plan to do next
- Reduce occupational road risk year‑on-year
- Continue to reduce recordable injuries
Community
Proactively engage in communities where Genus operates
Highlights in the year
- Recruited 146 staff into our PIC and ABS production sites
- Enhanced our range of placement and employment opportunities for students and apprentices
What we plan to do next
- Continue to respond to local community crises, recruit into local farms and encourage support for charities close to the local businesses and aligned with our mission
Governance
Our commitment to operating responsibly is ingrained within our company and overseen by the Board.
We have created a dedicated committee that reports to the Genus Executive Leadership Team (‘GELT’) on progress, performance and future plans. We have also established a sub-committee that focuses on animal well-being.
Corporate Social Responsibility Committee
The Corporate Social Responsibility Committee defines our strategy, reviews our policies and practices, monitors external developments and advises the GELT and the Audit & Risk Committee. It recommends annual goals and initiatives, and identifies the key performance indicators for monitoring and reporting our performance.
Organisation
The Committee comprises senior leaders who lead different aspects of the Corporate Responsibility programme; they meet quarterly to set objectives and review progress.
DAN HARTLEY (CHAIR OF COMMITTEE)
Group General Counsel and Company Secretary, Genus plc
Chair, Responsible for corporate responsibility delivery and compliance
VAUGHN WALTON (SECRETARY TO THE COMMITTEE)
Deputy Company Secretary, Genus plc
Secretary and corporate compliance
ANGELLE ROSATA
Group HR Director, Genus Plc
Leads on H&S aspects, community and people
IHAB AHMED
Head of Internal Audit, Genus plc
Responsible for integrity and risk mitigation
DR JER GEIGER, DVM, MS
Health Assurance Veterinarian, Genus PIC
Responsible for animal well-being and bio-security for PIC Americas
MARK LANE
Global Health & Safety Director, Genus plc
Responsible for global H&S
DR ANGEL MANABAT
Regional Technical Services and Health Assurance Director, Genus PIC
Responsible for animal well-being and environment for PIC Asia
DR JAMES MERONEK, DVM, MPH
Head of Global Health Assurance, Genus ABS
Responsible for animal well-being and bio-security for ABS globally
NICK MCCULLEY
Global Supply Chain Director, Genus PIC
Leads the global production of PIC, responsible for H&S implementation, environment and animal well-being
MARK SMITH
EMEA Beef Director, Genus ABS
Deeply knowledgeable about global production, Mark leads our ABS Beef business in Europe.
Sub-committee on animal well-being
This group focuses on animal well-being and also meets quarterly. It maintains an overview of the Company’s commitment to animal well-being and welfare, the well-being principles involved and the policies and activities developed to deliver these principles in practice.
DR. Bill Christianson (Chair of Committee)
Chief Operating Officer, Genus PIC
DR. Jim Meronek
Global Head of Health Assurance, Genus ABS
Nick McCulley
Global Supply Chain Director, Genus PIC
Mark Smith
EMEA Beef Director, Genus ABS
Steve Smith
Global Supply Chain Director, Genus ABS
DR. Dan Tucker
Global Health Assurance Advisor, Genus PIC